All stock lists
Doximity, Inc. (New York Stock Exchange:DOCS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
32.86-0.53 (-1.59%)
Insider Score
––Not scored
DOCS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
DOCS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 156.62 M | 145.37 M | 185.05 M | 168.53 M | 145.91 M | 138.29 M |
| Revenue Growth (YoY) | 7.34 % | 5.12 % | 9.76 % | 23.16 % | 15.19 % | 17.14 % |
| Cost of Revenue | 23.69 M | 19.41 M | 18.70 M | 16.43 M | 15.79 M | 14.47 M |
| Gross Profit | 132.93 M | 125.97 M | 166.35 M | 152.10 M | 130.12 M | 123.82 M |
| SG&A Expense | 60.80 M | 62.03 M | 59.86 M | 58.22 M | 48.80 M | 50.34 M |
| R&D Expense | 38.48 M | 39.11 M | 34.59 M | 30.20 M | 26.80 M | 24.80 M |
| Operating Expenses | 99.28 M | 101.14 M | 94.46 M | 88.42 M | 75.60 M | 75.14 M |
| Operating Income | 33.64 M | 24.83 M | 71.90 M | 63.68 M | 54.52 M | 48.68 M |
| Pretax Income | 40.36 M | 32.12 M | 80.80 M | 72.94 M | 64.15 M | 58.39 M |
| Tax Provision | 16.05 M | 13.01 M | 19.24 M | 10.88 M | 10.83 M | -4.06 M |
| Net Income | 24.32 M | 19.11 M | 61.56 M | 62.06 M | 53.32 M | 62.46 M |
| EPS (Basic) | 0.13 | 0.10 | 0.33 | 0.33 | 0.28 | 0.33 |
| EPS (Diluted) | 0.13 | 0.10 | 0.31 | 0.31 | 0.27 | 0.31 |
| Shares Outstanding | 182.57 M | 184.85 M | 187.48 M | 200.19 M | 187.98 M | 188.36 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.